Gastric bypass to improve blood sugar in obesity and type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests whether bariatric (weight-loss) surgery can improve blood sugar control in people with obesity and either prediabetes or type 2 diabetes. You may be enrolled in one of these glucose groups, and the researchers will monitor changes before and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 16 and 65 years old (with a mix of genders in the study)
- Have a BMI of 28 or higher, and be eligible for gastric surgery for weight loss
- Be in one of these blood-sugar groups based on HbA1c: prediabetes or type 2 diabetes (not type 1 diabetes)
- Understand the consent form and agree to follow the study rules and stay in good communication
- Not have had major weight loss in the 3 months before starting (over 3% weight loss)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut hormones and blood sugar control change after Roux-en-Y gastric bypass. It may help researchers understand what supports healthier glucose levels after bariatric surgery.
This study looks at which people with type 2 diabetes (or prediabetes) are most likely to benefit from bariatric surgery. It compares people who are planning surgery with healthy volunteers to better understand how body changes relate to blood sugar.
This study tests whether two weight-loss operations (sleeve gastrectomy or Roux-en-Y gastric bypass) can improve type 2 diabetes. It may help people with higher body weight and diabetes control, but it also requires meeting safety and health criteria.
This study tests whether weight-loss surgery improves how your body uses insulin and energy. It compares insulin sensitivity and related measurements before and after surgery to understand who benefits.
This trial tests a type of weight-loss surgery (called metabolic surgery) to see if it helps people with type 2 diabetes achieve better blood sugar control. It's for people who have struggled to manage their diabetes with standard treatments and have a BMI between 30 and 35.
This study looks at how inflammation affects heart disease and diabetes. It may help find new ways to prevent or treat these conditions.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.